---
title: "Acrivon Therapeutics (ACRV.US) — 财务报表"
type: "Symbol"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/quote/ACRV.US/norm.md"
symbol: "ACRV.US"
name: "Acrivon Therapeutics"
parent: "https://longbridge.com/zh-CN/quote/ACRV.US.md"
datetime: "2026-03-14T14:41:27.406Z"
locales:
  - [en](https://longbridge.com/en/quote/ACRV.US/norm.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/ACRV.US/norm.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/ACRV.US/norm.md)
---

> 支持的语言: [English](https://longbridge.com/en/quote/ACRV.US/norm.md) | [繁體中文](https://longbridge.com/zh-HK/quote/ACRV.US/norm.md)


# Acrivon Therapeutics (ACRV.US) — 财务报表

## 利润表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| EPS | -0.4729 | -0.5462 | -0.5132 | -0.5970 | -0.5889 |
| ROE | -53.70% | -55.38% | -46.69% | -48.88% | -43.47% |
| Revenue | - | - | - | - | - |
| Net income | -18.23M | -21.01M | -19.68M | -22.83M | -22.44M |
| Operating income | -19.69M | -22.65M | -21.66M | -24.95M | -25.14M |
| Gross margin | - | - | - | - | - |
| Net margin | - | - | - | - | - |
| Profit quality | - | - | - | - | - |

## 资产负债表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| A&L | 145.30M | 158.58M | 176.35M | 196.59M | 214.68M |
| Leverage | 1.13 | 1.11 | 1.10 | 1.11 | 1.09 |
| BVPS | 4.08 | 4.55 | 5.12 | 5.66 | 6.32 |
| Turnover | - | - | - | - | - |
| Cash & STI | 129.25M | 137.42M | 149.63M | 179.48M | 187.45M |
| Inv & Rec | - | - | - | - | - |
| LT assets | 7.98M | 8.12M | 7.98M | 8.03M | 8.47M |
| Net debt | -126.27M | -134.16M | -146.12M | -175.84M | -183.44M |

## 现金流量表 (USD)

| 指标 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
| --- | --- | --- | --- | --- | --- |
| Operating CF | -12.28M | -16.61M | -19.54M | -17.36M | -17.32M |
| Investing CF | 5.91M | 19.45M | 19.21M | 14.41M | 16.01M |
| Financing CF | -117000.00 | -97000.00 | -343000.00 | -647000.00 | -1.50M |
| Free CF | -7.64M | -9.85M | -12.75M | -10.65M | -9.02M |
| OCF coverage | -1366.30% | -3369.17% | -33681.03% | -2099.15% | -1751.57% |
| Repaid & issued | - | - | - | - | - |
| CapEx | -899000.00 | -493000.00 | -58000.00 | -827000.00 | -989000.00 |